Advertisement
Ascendis Pharma Says FDA Accepts Resubmitted NDA For TransCon PTH In Adults With Hypoparathyroidism
(RTTNews) - Ascendis Pharma A/S (ASND) announced Monday that the U.S. Food & Drug Administration (FDA) has accepted for review the Company's resubmitted New Drug Application (NDA) for TransCon PTH (palopegteriparatide) for the treatment of adult patients with hypoparathyroidism.
The agency considered the resubmission a complete, class 2 response and set a Prescription Drug User Fee Act (PDUFA) goal date of May 14, 2024.
In the United States, TransCon PTH (palopegteriparatide) is an investigational prodrug of parathyroid hormone (PTH [1-34]) for adult patients with hypoparathyroidism.
read more
Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism
Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom's Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism
RTTNews
|
462 hari yang lalu
Fed Leaves Interest Rates Unchanged In Divided Decision
The Federal Reserve on Wednesday announced its widely expected decision to leave interest rates unchanged for the fifth consecutive meeting. In support of its dual goals of maximum employment and inflation at the rate of 2 percent over the longer run, the Fed said it decided to maintain the target range for the federal funds rate at 4.25 to 4.50 percent.
RTTNews
|
2j 12min yang lalu
Swiss Market Settles Lower After Choppy Session
The Switzerland market ended on a weak note on Wednesday despite spending much of the day's trading session in positive territory. The focus was on corporate earnings and the developments on the trade front.
RTTNews
|
2j 37min yang lalu
European Stocks Close Mixed As Investors React To Earnings, Economic Data
European stocks turned in a mixed performance on Wednesday with investors largely reacting to earnings announcements, and awaiting the Federal Reserve's monetary policy announcement later in the day.
RTTNews
|
3j 2min yang lalu
Canadian Market Modestly Lower As Investors Digest Earnings, BoC Rate Decision
Canadian stocks are turning in a mixed performance on Wednesday with investors digesting Bank of Canada's policy announcement, and reacting to a slew of corporate earnings updates.
RTTNews
|
4j 4min yang lalu
U.S. Pending Home Sales Unexpectedly Decrease In June
Pending home sales in the U.S. unexpectedly decreased in the month of June, according to a report released by the National Association of Realtors on Wednesday. NAR said its pending home sales index slid by 0.8 percent to 72.0 in June after jumping by 1.8 percent to 72.6 in May. Economists had expected pending home sales to rise by 0.2 percent.
RTTNews
|
5j 38min yang lalu
Bank Of Canada Leaves Interest Rates Unchanged For Third Straight Meeting
In a widely expected move, the Bank of Canada on Wednesday announced that it has once again decided to leave interest rates unchanged. The Bank of Canada said it decided to maintain its target for the overnight rate at 2.75 percent, with the Bank Rate at 3 percent and the deposit rate at 2.70 percent.
RTTNews
|
6j 22min yang lalu
U.S. GDP Rebounds In Q2 Amid Sharp Pullback By Imports
The Commerce Department released a report on Wednesday showing the U.S. economy rebounded by more than expected in the second quarter of 2025. The report said real gross domestic product surged by 3.0 percent in the second quarter after falling by 0.5 percent in the first quarter. Economists had expected GDP to jump by 2.5 percent.
RTTNews
|
6j 32min yang lalu
